Halozyme Reports Second Quarter 2017 Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. LVS
6. SAP
7. CSX
8. LRCX
9. ELV
10. NDAQ

Go back to Halozyme Reports Second Quarter 2017 Results

Halozyme Therapeutics (HALO) Tops Q2 EPS by 1c

August 8, 2017 4:53 PM EDT

Halozyme Therapeutics (NASDAQ: HALO) reported Q2 EPS of ($0.23), $0.01 better than the analyst estimate of ($0.24). Revenue for the quarter came in at $33.8 million versus the consensus estimate of $31.76 million.

GUIDANCE:

Halozyme Therapeutics sees FY2017 revenue of $115-130 million, versus the consensus of... More